Lamivudin-Tenofovir disoproxil fumarate-300mg-300mg

Lamivudine-Tenofovir DF 300mg-300mg – Quick Overview

Lamivudine-Tenofovir Disoproxil Fumarate 300mg-300mg is a prescription two-drug combination tablet used with other antiretroviral medicines to treat HIV-1 infection in adults and eligible pediatric patients. It works by blocking an enzyme HIV needs to multiply, helping control the virus long-term. This medicine requires a valid prescription and consistent daily use as directed by your doctor.

Medical Supervision & Regulatory Status

Lamivudine-Tenofovir DF 300mg-300mg is available by prescription only in the United States and is regulated by the FDA (initial approval 2018). It is not sold over the counter, as HIV therapy requires careful regimen selection, kidney function monitoring, and hepatitis B testing before starting treatment.

Clinical Context

HIV-1 infection is a chronic viral condition that progressively weakens the immune system if left untreated, increasing the risk of serious infections and illness. Effective, consistent antiretroviral therapy is essential to keep the virus suppressed and preserve immune function.

Treatment is needed in individuals diagnosed with HIV-1 to reduce viral load to undetectable levels, lower the risk of transmission, and prevent disease progression to AIDS.

Within antiretroviral therapy, this combination provides two of the backbone nucleos(t)ide reverse transcriptase inhibitors in a single tablet, simplifying regimens when combined with a third agent from a different drug class, as recommended by current HIV treatment guidelines.

How Lamivudine-Tenofovir DF Works

This combination contains two nucleos(t)ide reverse transcriptase inhibitors (NRTIs): lamivudine and tenofovir disoproxil fumarate.

Both components work by interfering with reverse transcriptase, the enzyme HIV uses to convert its RNA into DNA, which is a necessary step for the virus to replicate inside human cells.

By blocking this process from two complementary angles, the combination helps reduce viral load, supporting immune system recovery when used correctly as part of a complete antiretroviral regimen.

What is Lamivudine-Tenofovir DF 300mg-300mg?

Uses / Indications

This combination is not a standalone HIV regimen and must always be paired with an additional antiretroviral from a different drug class as directed by a doctor.

How to Use / Dosage

Your doctor will confirm this combination is appropriate based on your kidney function, hepatitis B status, and overall treatment plan, since the fixed-dose tablet cannot be adjusted for reduced kidney function. It is generally taken once daily, with or without food, at the same time each day to maintain steady drug levels and support viral suppression. If you miss a dose, take it as soon as you remember unless it’s almost time for your next dose — in that case, skip the missed dose and resume your normal schedule without doubling up. Do not stop taking this medication without medical supervision, as interrupting therapy can lead to viral rebound, drug resistance, and — in patients also infected with hepatitis B — a severe flare of liver disease.

Side Effects

Many patients tolerate this combination well as part of long-term HIV therapy. Common side effects include headache, dizziness, nausea, diarrhea, fatigue, and trouble sleeping. Serious effects can include kidney problems, decreased bone density, lactic acidosis, and liver problems, particularly if hepatitis B co-infection is present and treatment is stopped abruptly.

Emergency Warning Signs — Seek immediate medical care if you experience:

• Severe stomach pain with nausea and vomiting
• Unusual muscle pain, weakness, or difficulty breathing
• Yellowing of the skin or eyes (jaundice)
• Decreased urination or swelling in the legs/ankles
• Bone pain or fractures with minimal trauma
• Signs of worsening hepatitis after stopping treatment
• Severe allergic reaction: rash, swelling, or trouble breathing

Warnings & Precautions

This combination carries a boxed warning for severe acute exacerbations of hepatitis B that can occur after stopping treatment in patients co-infected with HIV and hepatitis B; liver function must be monitored closely for several months after discontinuation, with resumption of anti-hepatitis B therapy considered if appropriate. It is not recommended for patients with creatinine clearance below 50 mL/min or those with end-stage renal disease requiring dialysis, since the fixed combination cannot be dose-adjusted for kidney impairment. Concurrent use with other products containing lamivudine, emtricitabine, tenofovir disoproxil fumarate, or tenofovir alafenamide should be avoided due to overlapping toxicity, and combination with adefovir dipivoxil is not recommended. Tenofovir disoproxil fumarate may decrease bone mineral density, so patients with a history of pathologic fracture or bone loss risk factors should be evaluated. Use during pregnancy and breastfeeding should be discussed with a doctor, and patients should be tested for HIV strain resistance and hepatitis B status before starting therapy.

Who Should Not Use This Medication

Known hypersensitivity to lamivudine, tenofovir disoproxil fumarate, or tablet components
Creatinine clearance below 50 mL/min or end-stage renal disease requiring hemodialysis
Concurrent use of other lamivudine-, emtricitabine-, or tenofovir-containing products
Concurrent use with adefovir dipivoxil
Patients unable to commit to consistent daily dosing or required monitoring

Storage Instructions

Store Lamivudine-Tenofovir DF 300mg-300mg tablets at room temperature, away from excess heat and humidity. Keep the tablets in their original, tightly closed container to protect from moisture and light. Always store out of reach and sight of children and pets, and dispose of unused medication safely through a take-back program.

Frequently Asked Questions

What is the cost of Lamivudine-Tenofovir DF 300mg-300mg without insurance?

This combination is available as a generic, which is generally more affordable than brand-name options. The cost without insurance depends on the seller, brand availability, and pack size, and may also vary by location and available discounts.

How can I order Lamivudine-Tenofovir DF online?

A valid prescription is required to order this medication. You can upload your prescription or have your doctor send it directly to a licensed pharmacy for home delivery. Always use verified, licensed pharmacies to ensure product safety and authenticity.

Is Lamivudine-Tenofovir DF available over the counter?

No, it is not available over the counter in most countries, including the United States. Regulations may vary by region, but ongoing medical supervision is required for HIV treatment.

Does Lamivudine-Tenofovir DF require a prescription?

Yes, a prescription is required in the U.S. and most countries. Medical evaluation, HIV resistance testing, and kidney and liver monitoring are necessary before and during treatment.

How long does it take for Lamivudine-Tenofovir DF to work?

Viral load typically begins decreasing within weeks of starting a complete antiretroviral regimen, with many patients reaching undetectable levels within a few months. Regular blood tests track your response to treatment.

Is it safe to stop Lamivudine-Tenofovir DF suddenly?

No, stopping suddenly can lead to viral rebound, drug resistance, and — in patients with hepatitis B co-infection a severe liver flare. Always consult your doctor before discontinuing, and continue monitoring afterward.

Can Lamivudine-Tenofovir DF interact with other medications?

Yes, it can interact with other tenofovir- or lamivudine-containing products, adefovir dipivoxil, and certain nephrotoxic drugs. Always share your full medication list with your doctor and pharmacist before starting treatment.

Resources

FDA Prescribing Information (Lamivudine and Tenofovir Disoproxil Fumarate Tablets): https://www.accessdata.fda.gov/drugsatfda_docs/pepfar/022344PI.pdf

WHO Public Assessment Report – Lamivudine/Tenofovir DF 300mg/300mg Tablets: https://extranet.who.int/prequal/sites/default/files/whopar_files/HA414part1v1.pdf

MedlinePlus – Lamivudine and Tenofovir Drug Information (NIH): https://medlineplus.gov/druginfo/meds/a612046.html

Medical Disclaimer:

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified specialist or physician before using Lamivudine-Tenofovir Disoproxil Fumarate 300mg-300mg.